Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation
| Autor: | Giulio G. Stefanini, Cosmo Godino, Astute Investigators, Gennaro Sardella, Rudi-Free, Mauro Chiarito |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Percutaneous business.industry medicine.medical_treatment Biolimus eluting stent Stent Polymer free 030204 cardiovascular system & hematology equipment and supplies Revascularization medicine.disease Surgery 03 medical and health sciences 0302 clinical medicine Diabetes mellitus medicine 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Adverse effect |
| Zdroj: | JACC: Cardiovascular Interventions. 12:1745-1747 |
| ISSN: | 1936-8798 |
| DOI: | 10.1016/j.jcin.2019.04.029 |
| Popis: | Despite impressive improvements in drug-eluting stent (DES) technologies, patients with diabetes remain at high risk for adverse events after percutaneous revascularization. Among novel DES, the Cre8 polymer-free amphilimus-eluting stent (AES) has shown promising results [(1)][1]. Recently, we |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|